miR-132 inhibits lipopolysaccharide-induced inflammation in alveolar macrophages by the cholinergic anti-inflammatory pathway
Experimental Lung Research · 28.05.2015 · 41 (5) · 261-269
DOI: 10.3109/01902148.2015.1004206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Lung Research, online erschienen am 08.06.2015. Verfasst von Fen Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Critical Care Medicine, the First Affiliated Hospital of Nanchang University , Nanchang, Jiangxi , China. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Although microRNA-132 (miR-132) has been shown to be involved in the inflammatory regulation, its role in sepsis-induced lung injury is unknown. We hypothesized that miR-132 attenuated lipopolysaccharide (LPS)-induced inflammation of alveolar macrophages by targeting acetylcholinesterase (AChE) and enhancing the acetylcholine (ACh)-mediated cholinergic anti-inflammatory response. METHODS: The LPS-treated rat alveolar macrophage cell line NR8383 was used as the inflammatory model. To assess the effect of miR-132, alveolar macrophages were transfected with miR-132 mimic or inhibitor. RESULTS: We found that miR-132 was upregulated in LPS-stimulated alveolar macrophages. Induction of AChE mRNA showed an inverse pattern with respect to AChE protein and activity, suggesting posttranscriptional regulation of AChE. Utilizing miR-132 mimic transfection, we found that overexpression of miR-132 enhanced the ACh-mediated cholinergic anti-inflammatory reaction by targeting AChE mRNA in LPS-treated alveolar macrophages. Blockage of miR-132 using miR-132 inhibitor reversed the Ach action upon LPS-induced release of inflammatory mediators and reduction in AchE protein/activity. Moreover, in the presence of ACh, upregulation of miR-132 suppressed LPS-induced nuclear translocation of NF-κB and production of STAT3 and phosphorylated STAT3, while downregulation of miR-132 enhanced the nuclear translocation of NF-κB. CONCLUSION: We propose that miR-132 functions as a negative regulator of the inflammatory response in alveolar macrophages by potentiating the cholinergic anti-inflammatory pathway, and represents a potential therapeutic leverage point in modulating inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Department of Critical Care Medicine, the First Affiliated Hospital of Nanchang University , Nanchang, Jiangxi , China.
Zitieren
APA
Liu, F., Li, Y., Jiang, R., Nie, C., Zeng, Z., Zhao, N., Huang, C., Shao, Q., Ding, C., Qing, C., Xia, L., Zeng, E., & Qian, K. (2015). miR-132 inhibits lipopolysaccharide-induced inflammation in alveolar macrophages by the cholinergic anti-inflammatory pathway. Experimental Lung Research, 41(5), 261-269. https://doi.org/10.3109/01902148.2015.1004206
Vancouver
Liu F, Li Y, Jiang R, Nie C, Zeng Z, Zhao N, et al. miR-132 inhibits lipopolysaccharide-induced inflammation in alveolar macrophages by the cholinergic anti-inflammatory pathway. Experimental Lung Research. 2015;41(5):261-269. doi:10.3109/01902148.2015.1004206
BibTeX
@article{Liu2015,
author = {Liu, Fen and Li, Yong and Jiang, Rong and Nie, Cheng and Zeng, Zhenguo and Zhao, Ning and Huang, Caixue and Shao, Qiang and Ding, Chengzhi and Qing, Cheng and Xia, Liang and Zeng, Erming and Qian, Kejian},
title = {miR-132 inhibits lipopolysaccharide-induced inflammation in alveolar macrophages by the cholinergic anti-inflammatory pathway},
journal = {Experimental Lung Research},
year = {2015},
volume = {41},
number = {5},
pages = {261--269},
doi = {10.3109/01902148.2015.1004206}
}
EUVIMED